Trial intelligence / Profile preview

Analgosedation Concepts During Placement of Regional Anaesthesia

NCT04026074Phase 4Completed

Sponsor
Medical University of Graz
Start
Jul 2019
Primary completion
Oct 2019
Modality
Drug Delivery Systems, Orthosteric Ligands
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of fentanyl (transdermal patch + oral transmucosal lozenge), remifentanil, clonidine and lidocaine + prilocaine in procedural pain (5 arms), sponsored by Medical University of Graz. Primary endpoint: Pain intensity during placement of the regional anaesthesia at 1 day. Started Jul 2019; status: completed.

02

Drugs

fentanyl (transdermal patch + oral transmucosal lozenge)remifentanilclonidinelidocaine + prilocaine
03

Conditions

procedural pain

Beyond the preview

Go deeper on NCT04026074.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04026074.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call